Masahiro Fuchigami
Overview
Explore the profile of Masahiro Fuchigami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arai R, Fuchigami M, Hatamura K, Yamamoto K, Yoshimatsu T
J Phys Ther Sci
. 2023 May;
35(5):384-388.
PMID: 37131348
[Purpose] Femoral neck fractures are a common problem resulting from balance impairment. Toe grip strength is related to balance function. This study aimed to confirm the type of balance function...
2.
Arai R, Fuchigami M, Yamamoto K, Hatamura K, Tatsuki Y
J Phys Ther Sci
. 2022 Feb;
34(2):99-102.
PMID: 35221511
[Purpose] This study aimed to compare the inter- and intra-examiner reliabilities of toe grip strength measurements obtained just above the first interphalangeal joint with those of toe grip strength measurements...
3.
Hariya N, Mochizuki K, Inoue S, Saito M, Fuchigami M, Goda T, et al.
Drugs R D
. 2014 Aug;
14(3):177-84.
PMID: 25079671
Background And Objectives: In this study we examined the effects of switching α-glucosidase inhibitors (α-GI) from acarbose or voglibose to miglitol on glucose fluctuations and circulating concentrations of cardiovascular disease...
4.
Imai C, Saito M, Mochizuki K, Fuchigami M, Goda T, Osonoi T
Metabolism
. 2014 Feb;
63(6):746-53.
PMID: 24559582
Objective: In this study, we examined whether inhibition of postprandial hyperglycemia by combination therapy with two drugs for reducing postprandial hyperglycemia, i.e., α-glucosidase inhibitor miglitol and dipeptidyl peptidase (DPP)-4 inhibitor...
5.
Hamada Y, Nagasaki H, Fuchigami M, Furuta S, Seino Y, Nakamura J, et al.
Metabolism
. 2012 Dec;
62(5):734-42.
PMID: 23194643
Objective: Alpha-glucosidase inhibitors (α-GIs) show various anti-diabetic or anti-obesity effects in addition to the suppression of postprandial hyperglycemia. Based on recent observations that bile acids (BAs) are involved in glucose...
6.
Okamoto M, Fuchigami M, Suzuki T, Watanabe N
Biol Pharm Bull
. 2012 Nov;
35(11):2069-74.
PMID: 23123476
C-C chemokine ligand 2 (CCL2)/its receptor (CCR2) axis is considered as an important signaling pathway in inflammatory diseases. TLK-19705 is a novel CCR2 antagonist, (1-(1,3-dimethyl-1-H-pyrazolo[3,4-b]pyridine-5-carbonyl)-3-(4-fluoro-3-(trifluoromethyl)phenyl)urea), and the inhibitory activity was...
7.
Nagasaki H, Kondo T, Fuchigami M, Hashimoto H, Sugimura Y, Ozaki N, et al.
FEBS Lett
. 2012 Jan;
586(4):368-72.
PMID: 22245676
In this study we aimed to identify the physiological roles of G protein-coupled receptor 84 (GPR84) in adipose tissue, together with medium-chain fatty acids (MCFAs), the specific ligands for GPR84....
8.
Mochizuki K, Fukaya N, Tanaka Y, Fuchigami M, Goda T
Metabolism
. 2011 May;
60(11):1560-5.
PMID: 21550076
Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes mellitus, exhibit chronic and slowly progressive hyperglycemia with obesity. In this study, we examined whether dietary supplementation...
9.
Osonoi T, Saito M, Mochizuki K, Fukaya N, Muramatsu T, Inoue S, et al.
Metabolism
. 2010 Jul;
59(12):1816-22.
PMID: 20667563
In this study, we examined the effects of switching from acarbose or voglibose to miglitol in type 2 diabetes mellitus patients for 3 months on gene expression of inflammatory cytokines/cytokine-like...
10.
Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, et al.
Eur J Pharmacol
. 2009 Oct;
624(1-3):51-7.
PMID: 19818342
The Otsuka Long-Evans Tokushima Fatty (OLETF) rat, an animal model of type 2 diabetes, exhibits obesity, hyperglycemia and hyperlipidemia, with late onset of chronic and slowly progressive hyperinsulinemia. In this...